EUVIMEDEUVIMED entdecken
Open Access

Discovery of a Potent, Selective, and Cell-Active SPIN1 Inhibitor

Yan Xiong, Holger Greschik, Catrine Johansson, Ludwig Seifert, Vicki Gamble, Kwang-Su Park iD, Vincent Fagan, Fengling Li, Irene Chau, Masoud Vedadi, Cheryl H Arrowsmith, Paul Brennan und 7 weitere

Journal of Medicinal Chemistry · 11.04.2024 · 67 (7) · 5837-5853

DOI: 10.1021/acs.jmedchem.4c00121 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 27.03.2024. Verfasst von Yan Xiong und 18 weiteren Autor:innen. Beteiligte Einrichtung: Mount Sinai Center for Therapeutics Discovery, Departments of Pharmacological Sciences, Oncological Sciences and Neuroscience, Tisch Cancer Institute…. Hauptthemen laut MEDLINE: Tudor Domain, Lysine. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, Cancer Research UK, Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The methyl-lysine reader protein SPIN1 plays important roles in various human diseases. However, targeting methyl-lysine reader proteins has been challenging. Very few cellularly active SPIN1 inhibitors have been developed. We previously reported that our G9a/GLP inhibitor UNC0638 weakly inhibited SPIN1. Here, we present our comprehensive structure-activity relationship study that led to the discovery of compound 11, a dual SPIN1 and G9a/GLP inhibitor, and compound 18 (MS8535), a SPIN1 selective inhibitor. We solved the cocrystal structure of SPIN1 in complex with 11, confirming that 11 occupied one of the three Tudor domains. Importantly, 18 displayed high selectivity for SPIN1 over 38 epigenetic targets, including G9a/GLP, and concentration dependently disrupted the interactions of SPIN1 and H3 in cells. Furthermore, 18 was bioavailable in mice. We also developed 19 (MS8535N), which was inactive against SPIN1, as a negative control of 18. Collectively, these compounds are useful chemical tools to study biological functions of SPIN1.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tudor DomainLysineHumansAnimalsMiceStructure-Activity Relationship

Substanzen

methyl-lysineLysine

Autor:innen und Institutionen

  • Mount Sinai Center for Therapeutics Discovery, Departments of Pharmacological Sciences, Oncological Sciences and Neuroscience, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York 10029, U…
  • Department of Urology and Center for Clinical Research, University Freiburg Medical Center, Freiburg 79106, Germany.
  • Structural Genomics Consortium, Botnar Research Center, NIHR Oxford BRU, University of Oxford, Oxford OX3 7LD, U.K.
  • Institute of Pharmaceutical Sciences, University of Freiburg, Freiburg 79104, Germany.
  • Centre for Medicines Discovery, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, U.K.; Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, U.K.
  • Structural Genomics Consortium, University of Toronto, Toronto, Ontario M5G 1L7, Canada.

ORCID-Profile: Kwang-Su Park, Manfred Jung, Jian Jin

Förderung

  • NIH HHS
  • Cancer Research UK
  • Deutsche Forschungsgemeinschaft
  • National Institutes of Health
  • Fondation Leducq

Zitieren

APA

Xiong, Y., Greschik, H., Johansson, C., Seifert, L., Gamble, V., Park, K. S., Fagan, V., Li, F., Chau, I., Vedadi, M., Arrowsmith, C. H., Brennan, P., Fedorov, O., Jung, M., Farnie, G., Liu, J., Oppermann, U., Schüle, R., & Jin, J. (2024). Discovery of a Potent, Selective, and Cell-Active SPIN1 Inhibitor. Journal of Medicinal Chemistry, 67(7), 5837-5853. https://doi.org/10.1021/acs.jmedchem.4c00121

Vancouver

Xiong Y, Greschik H, Johansson C, Seifert L, Gamble V, Park KS, et al. Discovery of a Potent, Selective, and Cell-Active SPIN1 Inhibitor. Journal of Medicinal Chemistry. 2024;67(7):5837-5853. doi:10.1021/acs.jmedchem.4c00121

BibTeX
@article{Xiong2024,
  author = {Xiong, Yan and Greschik, Holger and Johansson, Catrine and Seifert, Ludwig and Gamble, Vicki and Park, Kwang-Su and Fagan, Vincent and Li, Fengling and Chau, Irene and Vedadi, Masoud and Arrowsmith, Cheryl H and Brennan, Paul and Fedorov, Oleg and Jung, Manfred and Farnie, Gillian and Liu, Jing and Oppermann, Udo and Schüle, Roland and Jin, Jian},
  title = {Discovery of a Potent, Selective, and Cell-Active SPIN1 Inhibitor},
  journal = {Journal of Medicinal Chemistry},
  year = {2024},
  volume = {67},
  number = {7},
  pages = {5837--5853},
  doi = {10.1021/acs.jmedchem.4c00121}
}
Kostenlos starten →